- Home
- ANVS vs GGZ Comparison
ANVS vs GGZ Comparison
Compare ANVS & GGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$3.66
Company Overview
Basic Information| Metric | ANVS | GGZ |
|---|---|---|
| Founded | 2008 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 111.3M | 112.4M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ANVS | GGZ |
|---|---|---|
| Price | $3.66 | $14.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $13.50 | N/A |
| AVG Volume (30 Days) | ★ 979.7K | 12.8K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.39% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.75 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $6.79 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.11 | $9.43 |
| 52 Week High | $5.60 | $12.50 |
Technical Indicators
Market Signals| Indicator | ANVS | GGZ |
|---|---|---|
| Relative Strength Index (RSI) | 48.59 | 67.00 |
| Support Level | $3.46 | $14.42 |
| Resistance Level | $4.04 | $14.95 |
| Average True Range (ATR) | 0.36 | 0.15 |
| MACD | -0.14 | 0.06 |
| Stochastic Oscillator | 15.43 | 93.41 |
Price Performance
Historical Comparison ANVS
GGZ
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
About GGZ Gabelli Global Small and Mid Cap Value Trust (The) of Beneficial Interest
The Gabelli Global Small and Mid Cap Value Trust is a diversified closed-ended management investment company whose investment objective is long-term capital growth. It invests in equity securities such as common stock and preferred stock of companies.